Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
The Annals of Thoracic Surgery
|
December 4, 2008
Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes
Julie E Bauman, Michael S Mulligan, Renato G Martins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 4, 2018
Pregnancy Screening in Patients With Cancer
Annika M Gustafson, Deborah J Goldfrank, William A Dunson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 7, 2018
Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility
Keith D Eaton, Perrin E Romine, Gary E Goodman, et al.
JCO Oncology Practice
|
August 10, 2021
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer
Cristina Merkhofer, Shasank Chennupati, Qin Sun, et al.
Diabetes Care
|
June 28, 2015
Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes
Mahnaz Mellati, Keith D Eaton, Barbara M Brooks-Worrell, et al.
JCO Oncology Practice
|
February 4, 2022
Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database
Perrin E Romine, Qin Sun, Catherine Fedorenko, et al.
Head & Neck
|
December 29, 2017
Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies
Cristina P Rodriguez, Renato G Martins, Christina Baik, et al.
Cancer Treatment and Research Communications
|
June 12, 2021
A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy
Christina Baik, Sylvia Lee, Kitty Cook, et al.
Clinical Lung Cancer
|
March 8, 2023
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study
Melissa L Johnson, James Strauss, Manish R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2010
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation
Laurie L Carr, David A Mankoff, Bernardo H Goulart, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
The Annals of Thoracic Surgery
|
December 4, 2008
Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes
Julie E Bauman, Michael S Mulligan, Renato G Martins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 4, 2018
Pregnancy Screening in Patients With Cancer
Annika M Gustafson, Deborah J Goldfrank, William A Dunson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 7, 2018
Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility
Keith D Eaton, Perrin E Romine, Gary E Goodman, et al.
JCO Oncology Practice
|
August 10, 2021
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer
Cristina Merkhofer, Shasank Chennupati, Qin Sun, et al.
Diabetes Care
|
June 28, 2015
Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes
Mahnaz Mellati, Keith D Eaton, Barbara M Brooks-Worrell, et al.
JCO Oncology Practice
|
February 4, 2022
Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database
Perrin E Romine, Qin Sun, Catherine Fedorenko, et al.
Head & Neck
|
December 29, 2017
Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies
Cristina P Rodriguez, Renato G Martins, Christina Baik, et al.
Cancer Treatment and Research Communications
|
June 12, 2021
A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy
Christina Baik, Sylvia Lee, Kitty Cook, et al.
Clinical Lung Cancer
|
March 8, 2023
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study
Melissa L Johnson, James Strauss, Manish R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2010
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation
Laurie L Carr, David A Mankoff, Bernardo H Goulart, et al.
Page
of 6